| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $2,716,279 ) |
| | 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA193842 | Characterizing the MSI2 network in leukemia | 000 | 10 | NIH | 11/15/2024 | $371,921 |
| | 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA248364 | Leveraging fructose transport to create a privileged substrate to selectively fuel T cells | 000 | 5 | NIH | 11/6/2024 | $627,094 |
| | 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R25CA214255 | Quantitative Sciences Summer Undergraduate Research Experience (QSURE) | 000 | 8 | NIH | 11/15/2024 | $153,064 |
| | 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG080684 | Molecular mechanisms of gamma-secretase modulation central to Alzheimer’s disease | 000 | 3 | NIH | 11/15/2024 | $723,560 |
| | 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K08CA259161 | Uncovering Epigenetic and Transcriptional Drivers of Neuroendocrine Plasticity at Single-Cell Level in Patients with Small Cell Lung Cancer Transformation | 000 | 4 | NIH | 11/15/2024 | $278,198 |
| | 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA276946 | Defining Mechanisms of Progression and Treatment Resistance in Localized Bladder Cancer | 000 | 3 | NIH | 11/15/2024 | $462,767 |
| | 2025 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA244233 | Improving radiolabeled imaging and targeting of HER2 positive EG cancers using lovastatin | 000 | 5 | NIH | 11/12/2024 | $626,130 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM144046 | Regulation of protein multi-functionality by 3 UTRs | 000 | 3 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K99CA283664 | The crosstalk between obesity-induced fatty liver and liver metastasis | 000 | 1 | NIH | 11/15/2024 | $0 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA293922 | Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy | 000 | 1 | NIH | 11/15/2024 | $0 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM118080 | Structural studies of RNA processing and ubiquitin-like protein modification | 000 | 9 | NIH | 11/15/2024 | $0 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM145260 | Regulation of genome replication, recombination, and stress response | 000 | 3 | NIH | 11/15/2024 | $0 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K99AI175599 | Unraveling the ecology of intestinal fungal expansion in immunocompromised patients through computational modeling and machine learning | 000 | 1 | NIH | 11/14/2024 | $0 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM131858 | Interrogating Complex Methylome Network with Integrated Chemical Biology Tools | 000 | 6 | NIH | 11/15/2024 | $0 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM126907 | Mechanisms of DNA Replication, Chromosome Compaction, and Chromosome Unlinking | 000 | 7 | NIH | 11/14/2024 | $0 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM126945 | Mechanisms of DNA and RNA Transactions | 000 | 7 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM152094 | Molecular mechanism of eukaryotic chromosome replication | 000 | 1 | NIH | 11/11/2024 | $0 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R25CA272282 | Genomics Research Experience for Master's Students (GEMS) Fellowship | 000 | 2 | NIH | 11/11/2024 | $0 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA284134 | Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk | 000 | 1 | NIH | 11/4/2024 | -$362,465 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA292664 | Tuning KITv CAR T cells for the solid tumor environment | 000 | 1 | NIH | 11/7/2024 | -$3,722 |
| | 2025 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM136278 | DNA Damage & DNA Replication: a Complex Relationship | 000 | 5 | NIH | 11/4/2024 | $0 |
| | 2025 | 2023 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | F32CA257103 | The role and regulation of p53 in obesity-induced liver cancer | 000 | 3 | NIH | 10/23/2024 | -$2,609 |
| | 2025 | 2023 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA231021 | Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis | 000 | 6 | NIH | 10/17/2024 | $0 |
| | 2025 | 2022 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U01CA225431 | Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer | 000 | 6 | NIH | 10/18/2024 | -$37,525 |
| | 2025 | 2022 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U01CA221046 | Pretargeted Clinical Imaging of CA19.9 in Pancreatic Cancer | 000 | 5 | NIH | 10/17/2024 | -$69,720 |
| | 2025 | 2022 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R00CA230205 | Uncovering Roles of Metabolites in Colorectal Cancer Etiology | 000 | 5 | NIH | 11/5/2024 | -$35,789 |
| | 2025 | 2022 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | T32CA009685 | Head and Neck Training Program in Surgical Oncology | 000 | 30 | NIH | 10/21/2024 | -$14,238 |
| | 2025 | 2020 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA251992 | Proteomic Characterization of Genomically Complex Sarcomas | 001 | 1 | NIH | 11/5/2024 | -$386 |
| | 2025 | 2020 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA251992 | Proteomic Characterization of Genomically Complex Sarcomas | 000 | 1 | NIH | 11/5/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $204,496,807 ) (Continued on the next page) |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U01CA238444 | Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR) | 000 | 5 | NIH | 8/19/2024 | $623,923 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | UG1CA233332 | ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC) | 002 | 6 | NIH | 7/5/2024 | $0 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM138386 | Investigating histone glycation as a new dynamic epigenetic mark | 001 | 5 | NIH | 6/24/2024 | $43,921 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA288502 | Social Genomic Mechanisms Linking Structural Racism, Perceived Discrimination, and Breast Cancer Survival | 000 | 1 | NIH | 8/23/2024 | $582,548 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01EB032825 | Artificial Intelligence powered virtual digital twins to construct and validate AI automated tools for safer MR-guided adaptive RT of abdominal cancers | 000 | 2 | NIH | 8/1/2024 | $493,493 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U01CA243644 | Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients | 000 | 5 | NIH | 8/1/2024 | $738,070 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21EB033985 | Rapid Free-Breathing 3D High-Resolution MRI for Volumetric Liver Iron Quantification | 000 | 2 | NIH | 7/19/2024 | $265,500 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K08CA245206 | Exploring the combinatorial efficacy between chemotherapy and T cell checkpoint inhibition and the role of cellular senescence | 000 | 5 | NIH | 6/26/2024 | $260,099 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVENUE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM129058 | Replication Of Chromosomes In Budding Yeast | 001 | 5 | NIH | 12/27/2023 | $460,223 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVENUE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM129058 | Replication Of Chromosomes In Budding Yeast | 002 | 5 | NIH | 1/12/2024 | -$2,600 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVENUE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA285621 | Meaning-Centered Psychotherapy to Meet Palliative Care Needs of Cancer Caregivers | 001 | 1 | NIH | 1/12/2024 | -$1,871 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVENUE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | UG1CA233332 | ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC) | 000 | 6 | NIH | 2/26/2024 | $803,440 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVENUE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA285621 | Meaning-Centered Psychotherapy to Meet Palliative Care Needs of Cancer Caregivers | 000 | 1 | NIH | 1/1/2024 | $444,572 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVENUE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA238552 | Genomic biomarkers for cutaneous T-cell Lymphoma | 000 | 6 | NIH | 1/24/2024 | $310,098 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVENUE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | UG1CA233332 | ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC) | 001 | 6 | NIH | 4/17/2024 | $44,635 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVENUE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA249666 | HER2-mediated delivery of cytotoxic agents in solid tumors | 001 | 4 | NIH | 4/17/2024 | $29,390 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVENUE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA238552 | Genomic biomarkers for cutaneous T-cell Lymphoma | 001 | 6 | NIH | 4/17/2024 | $17,225 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVENUE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM138386 | Investigating histone glycation as a new dynamic epigenetic mark | 000 | 5 | NIH | 4/10/2024 | $395,280 |
| | 2024 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVENUE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA249666 | HER2-mediated delivery of cytotoxic agents in solid tumors | 000 | 4 | NIH | 3/11/2024 | $529,009 |
|
